Home / Technology / Challenges of Calcium

Finally, Calcium Will Meet Its Match

Promising Treatments Have Come Up Short In Addressing the Growing Burden of Calcium

calcium header 1

Current Landscape of

Calcium Burden and Modification Tools

Global Population Ages = Incidence of Cardiovascular Calcium On the Rise
Calcium Increases Case Complexity & Decreases Treatment Effectiveness
Conventional Treatment Options Can Be Difficult to Learn, Perform and Master
Patients at an Increased Risk for Adverse Events Due to Calcium and Modification Tools
Learn More About IVL

One of the reasons problematic calcium in cardiovascular disease has long been associated with worse clinical outcomes is that

existing solutions face common limitations.

dilate img

Unable to Dilate

High pressure balloons and modified balloons, such as scoring and cutting balloons, aren’t able to reliably dilate vessels containing rigid, severe calcium.
calcium right

Don't Address Deep Calcium

Current technologies – including high pressure and modified balloons, as well as atherectomy – only treat superficial calcium, leaving deep calcium unaddressed and potentially impacting procedural outcomes.1
1. Rocha-Singh et al, Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications, Catheter Cardiovasc Interv, 2014
Learn More about IVL

Furthermore, conventional solutions have
inadequately addressed calcium by requiring physicians to make tradeoffs
when treating calcified lesions, including:

Increased
Risk
Increasing the risk of severe adverse events, including major dissections, perforation and distal emboli
Soft Tissue
Harm
Damaging the soft intimal tissue in order to modify the calcium
Additional
Cost
Incurring additional costs for secondary therapies when first-line therapies fail
Complicated
Tech
Performing complex cases with complicated technology and unpredictable outcomes

Ready to Make Waves with Shockwave IVL?

ico email Connect

We're excited about IVL's potential in aortic stenosis, too!

But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.

MORE ON TAVR ENABLING TRANSFEMORAL ACCESS
SIGN UP FOR UPDATES ON OUR VALVE R&D PROGRAM

Get Crackin with Shockwave IVL Today

Thanks for contacting us! We will get in touch with you shortly.

Wow - you're ready to start cracking, aren't you?

Too bad our coronary technology is not yet approved in the United States. Good news is that we have initiated our U.S. FDA IDE study. Learn more about the Disrupt CAD III study on our clinical research portion of the website.

About Disrupt CAD III
No Thanks
Disrupt

IT’S TIME TO

GET CRACKING

COUNTDOWN TO CAD III PRESENTATION

Days

Hours

Minutes

Seconds

TCT CONNECT
LEARN MORE ABOUT CAD III

Caution: Investigational device. Limited by Federal (U.S.) law to investigational use.
ISI: https://shockwavemedical.com/important-safety-information-coronary/